Alar Ainla

Alar Ainla is a Research Scientist and Principal Investigator at the International Iberian Nanotechnology Laboratory (INL), leading the Medical Devices group within the Diéguez Research Group. His work focuses on integrated microfluidic systems and sensors for life-science applications, spanning micro- and nanofluidics, electroanalytical chemistry, and medical device development.

Education:

• BSc cum laude in Applied Physics and Information Technology, University of Tartu (Estonia)
• MSc in Nanoscience and Technology, Chalmers University of Technology (Sweden)
• PhD in Chemistry, Chalmers University of Technology (Sweden)

Dr. Ainla's research integrates cell culture, electrochemical sensing, and microfluidic engineering to create diagnostic tools for cancer research and point-of-care applications. His expertise extends to soft robotics and open-source hardware development, reflecting a strong interdisciplinary approach at the intersection of chemistry, engineering, and biomedical sciences.

Publication trends reveal a progression from fundamental microfluidic tools (2012-2017) toward applied medical diagnostics (2018-2021), with significant contributions in electrochemical sensing for 3D cell cultures and wireless detection systems. His work consistently bridges laboratory innovation with real-world medical applications.

Dr. Ainla actively engages in science entrepreneurship, having co-founded startups focused on technology development and intellectual property management. His participation in Harvard Innovation Labs (iLab) and entrepreneurship programs at Harvard Business School underscores his commitment to translating research into commercial solutions.